AstraZeneca buys US biopharma firm Fusion for up to $2.4 bn
Anglo-Swedish pharmaceuticals giant AstraZeneca on Tuesday agreed to buy US biopharma firm Fusion for up to $2.4 billion, in the…
AstraZeneca buys US biopharma firm Fusion for up to $2.4 bn
Anglo-Swedish pharmaceuticals giant AstraZeneca on Tuesday agreed to buy US biopharma firm Fusion for up to $2.4 billion, in the…